Abbott Laboratories (ABT) stock forecast — our track record

Lyra published 11 ABT stock forecasts beginning July 11, 2025. Each prediction was published before its outcome was known, then closed and scored after its full forecast window ended. All 11 calls used the short term horizon (0 to 3 months). The last window ended July 27, 2026, so every forecast included here had a completed result rather than an open outcome.

Three forecasts reached their targets, while none of them missed. The other 8 calls received partial credit because the stock moved in the predicted direction without fully reaching the stated target. Across all 11 completed calls, the average success score was 59.1%. The average peak gain was 5.3%. Since every call used the same short term horizon, there was no medium term or long term record to compare with it.

The best call was published April 27, 2026. It predicted 12% growth over the short term, and the stock rose 13% at its peak. The target was reached after 88 days, and the call received a 100% score. The weakest call was published January 6, 2026. It predicted 10% growth, but the stock rose only 0.9% at its peak and did not reach the target. That call received a 50% score. Overall, the track record was mixed: three calls fully reached their targets, while 8 moved partly toward them and no call was scored as a miss.